197 related articles for article (PubMed ID: 31376734)
1. In silico probing exercises, bioactive-conformational and dynamic simulations strategies for designing and promoting selective therapeutics against Helicobacter pylori strains.
Pasala C; Katari SK; Nalamolu RM; Bitla AR; Amineni U
J Mol Graph Model; 2019 Nov; 92():167-179. PubMed ID: 31376734
[TBL] [Abstract][Full Text] [Related]
2. Integration of core hopping, quantum-mechanics, molecular mechanics coupled binding-energy estimations and dynamic simulations for fragment-based novel therapeutic scaffolds against Helicobacter pylori strains.
Pasala C; Katari SK; Nalamolu RM; Aparna RB; Amineni U
Comput Biol Chem; 2019 Dec; 83():107126. PubMed ID: 31557645
[TBL] [Abstract][Full Text] [Related]
3. Hierarchical-Clustering, Scaffold-Mining Exercises and Dynamics Simulations for Effectual Inhibitors Against Lipid-A Biosynthesis of
Pasala C; Katari SK; Nalamolu RM; Bitla AR; Amineni U
Cell Mol Bioeng; 2019 Jun; 12(3):255-274. PubMed ID: 31719913
[TBL] [Abstract][Full Text] [Related]
4. Novel and potent inhibitors for dihydropteroate synthase of
Satuluri SH; Katari SK; Pasala C; Amineni U
J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
[TBL] [Abstract][Full Text] [Related]
5. Identification of Helicobacter pylori-carcinogenic TNF-alpha-inducing protein inhibitors via daidzein derivatives through computational approaches.
Tayyeb JZ; Mondal S; Anisur Rahman M; Kumar S; Bayıl I; Akash S; Hossain MS; Alqahtani T; Zaki MEA; Oliveira JIN
J Cell Mol Med; 2024 May; 28(9):e18358. PubMed ID: 38693868
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from
Tabassum H; Ahmad IZ
Med Chem; 2021; 17(2):146-157. PubMed ID: 32116195
[TBL] [Abstract][Full Text] [Related]
7. Epitope-driven common subunit vaccine design against
Pasala C; Chilamakuri CSR; Katari SK; Nalamolu RM; Bitla AR; Amineni U
J Biomol Struct Dyn; 2019 Sep; 37(14):3740-3750. PubMed ID: 30580658
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
9. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
[TBL] [Abstract][Full Text] [Related]
10. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
Mandal RS; Das S
J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
[TBL] [Abstract][Full Text] [Related]
11. Atomic level and structural understanding of natural ligands inhibiting
Sunder Raj D; Kesavan DK; Kottaisamy CPD; Kumar VP; Hopper W; Sankaran U
J Biomol Struct Dyn; 2023 May; 41(8):3440-3461. PubMed ID: 35293845
[No Abstract] [Full Text] [Related]
12. Screening approaches against claudin-4 focusing on therapeutics through molecular docking and the analysis of their relative dynamics: a theoretical approach.
Rambabu M; Jayanthi S
J Recept Signal Transduct Res; 2020 Oct; 40(5):436-441. PubMed ID: 32321343
[TBL] [Abstract][Full Text] [Related]
13. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
Saxena S; Durgam L; Guruprasad L
J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
[TBL] [Abstract][Full Text] [Related]
14. Integration of virtual screening and susceptibility test to discover active-site subpocket-specific biogenic inhibitors of Helicobacter pylori shikimate dehydrogenase.
Wang K; Zhu M; Tang Y; Liu J; Yan F; Yu Z; Zhu J
Int Microbiol; 2019 Mar; 22(1):69-80. PubMed ID: 30810934
[TBL] [Abstract][Full Text] [Related]
15. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
Paul M; Kumar Panda M; Thatoi H
J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
[TBL] [Abstract][Full Text] [Related]
16. In Silico study of the active site of Helicobacter pylori urease and its inhibition by hydroxamic acids.
Arora R; Issar U; Kakkar R
J Mol Graph Model; 2018 Aug; 83():64-73. PubMed ID: 29775804
[TBL] [Abstract][Full Text] [Related]
17. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
John A; Vetrivel U; Subramanian K; Deepa PR
J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
[TBL] [Abstract][Full Text] [Related]
18. In silico trials to design potent inhibitors against matrilysin (MMP-7).
Katari SK; Pasala C; Nalamolu RM; Bitla AR; Umamaheswari A
J Biomol Struct Dyn; 2022; 40(22):11851-11862. PubMed ID: 34405760
[TBL] [Abstract][Full Text] [Related]
19. Design of novel lead molecules against RhoG protein as cancer target - a computational study.
Dasari T; Kondagari B; Dulapalli R; Abdelmonsef AH; Mukkera T; Padmarao LS; Malkhed V; Vuruputuri U
J Biomol Struct Dyn; 2017 Nov; 35(14):3119-3139. PubMed ID: 27691842
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking and dynamic simulation evaluation of Rohinitib - Cantharidin based novel HSF1 inhibitors for cancer therapy.
Agarwal T; Annamalai N; Khursheed A; Maiti TK; Arsad HB; Siddiqui MH
J Mol Graph Model; 2015 Sep; 61():141-9. PubMed ID: 26245696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
